Type of security: Stock
Sector: Health Care
Industry: Hospital/Nursing Management
Market Capitalization: 26.66 B
The data is delayed by 15 minutes.
Description: Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides renal dialysis products and services. It offers dialysis treatment, and related laboratory and diagnostic services through its network of 3,250 outpatient dialysis clinics in approximately 45 countries worldwide; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also provides pharmacy services, such as delivery and supply of renal medications to patients at homes or to dialysis clinics directly; vascular access surgery services; and manufactures and distributes products for the treatment of end-stage renal disease (ESRD). In addition, it offers laboratory services that include blood, urine, and other bodily fluid testing services; and hemodialysis (HD) m
|Shares Outstanding||610.73 M||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||-20.08%||Sales Growth - 4 Quarters||Sales Growth - Q/Q||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||28.67||ROA||ROE||ROI|
|Current Ratio||Quick Ratio||Long Term Debt/Equity||Debt Ratio|
|Gross Margin||Operating Margin||Net Profit Margin||Dividend Payout Ratio|
|Cash From Financing Activities||-237.29 M||Cash From Investing Activities||-208.84 M||Cash From Operating Activities||447.27 M||Gross Profit||1.18 B|
|Net Profit||209.55 M||Operating Profit||504.4 M||Total Assets||25.11 B||Total Current Assets||6.6 B|
|Total Current Liabilities||3.55 B||Total Debt||9.05 B||Total Liabilities||15.56 B||Total Revenue||3.96 B|
|High 52 week||53.37||Low 52 week||31.1||Last close||33.66||Last change||0.21%|
|RSI||18.62||Average true range||0.76||Beta||0.62||Volume||94.68 K|
|Simple moving average 20 days||-7.54%||Simple moving average 50 days||-10.64%||Simple moving average 200 days||-14.55%|
|Performance Week||-1.69%||Performance Month||-15%||Performance Quart||-16.97%||Performance Half||3.31%|
|Performance Year||-32.69%||Performance Year-to-date||3.92%||Volatility daily||1.9%||Volatility weekly||4.25%|
|Volatility monthly||8.71%||Volatility yearly||30.18%||Relative Volume||258.11%||Average Volume||230.29 K|
|New High||New Low|
2019-09-06 00:13:38 | Should You Worry About Fresenius Medical Care AG & Co. KGaA's ETR:FME CEO Pay Cheque?
2019-09-05 11:23:24 | Huge Southaven laboratory could mean more than 300 jobs
2019-08-22 09:30:01 | Is Fresenius Medical FMS a Good Value Investor Pick Now?
2019-08-19 00:02:13 | Should You Be Impressed By Fresenius Medical Care AG & Co. KGaA's ETR:FME ROE?
2019-08-07 21:24:51 | Cytosorbents CTSO Q2 2019 Earnings Call Transcript
2019-08-06 11:47:03 | 3 Marijuana Stocks to Play the Future of Cannabis Medicine
2019-08-01 00:00:18 | What Should You Know About Fresenius Medical Care AG & Co. KGaA's ETR:FME Growth?
2019-07-31 09:10:01 | Fresenius Medical FMS Q2 Earnings Miss Estimates, Down Y/Y
2019-07-30 18:23:44 | Fresenius Medical Care AG & Co. KGaA FMS Q2 2019 Earnings Call Transcript
2019-07-30 01:52:17 | UPDATE 1-Fresenius raises 2019 sales outlook after Q2 hits targets
2019-07-30 00:59:42 | Fresenius Medical Care confirms 2019 targets
2019-07-29 12:38:02 | 3 Large-Cap Stocks Offer High Earnings Yields
2019-07-29 04:15:00 | Celebrating Nurses: The Hearts and Souls of Fresenius Kidney Care
2019-07-18 00:02:55 | Is It Too Late To Consider Buying Fresenius Medical Care AG & Co. KGaA ETR:FME?
2019-07-17 16:00:13 | CVS Health Tests Home Dialysis System; DaVita, Fresenius Hit
2019-07-17 08:00:00 | CVS enters home dialysis care with clinical trial of new system
2019-07-12 10:28:02 | The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS
2019-07-12 07:00:00 | Home Dialysis to Benefit These Undervalued Providers
2019-07-11 09:20:01 | Trump's Order on Kidney Care Lifts These Dialysis Stocks
2019-07-10 17:32:09 | Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others
2019-07-10 16:58:16 | Trump Calls for Overhaul of Costly Kidney Dialysis Program
2019-07-10 15:05:26 | Trump's executive order on kidney health lifts dialysis company stocks
2019-07-10 09:58:10 | UPDATE 3-Trump administration pushes U.S. at-home kidney care, transplant availability
2019-07-10 00:38:43 | Trump Targets Dialysis, Kidney Transplants in Care Overhaul
2019-07-09 12:37:14 | Trump’s Next Phase on Health Care: Everywhere and Nowhere
2019-07-09 07:48:11 | Fresenius Set for Global Expansion of Research Activities
2019-07-09 07:12:00 | DaVita Lower as HHS Plans to Emphasize At-Home Dialysis Treatment
2019-07-02 07:16:00 | Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
2019-06-30 02:14:34 | Does Fresenius Medical Care AG & Co. KGaA's ETR:FME Debt Level Pose A Problem?
2019-06-27 16:34:00 | These European companies benefit from high health-care prices in the U.S.
2019-06-06 02:00:21 | INSIGHT-Will Europe's clampdown on faulty medical devices hurt patients?
2019-06-02 09:09:00 | Is Cara Therapeutics a Buy Now?
2019-05-30 07:48:11 | Cara Shares Up on Positive Phase III Data for Itchiness Drug
2019-05-29 13:00:00 | Fresenius Medical Care Breaks Ground on Knoxville Distribution Center
2019-05-06 11:05:03 | Fresenius Medical FMS Q1 Earnings & Revenues Top Estimates
2019-05-02 15:24:26 | Edited Transcript of FME.DE earnings conference call or presentation 2-May-19 1:30pm GMT
2019-05-02 12:56:14 | Fresenius makes solid start to year after turbulent 2018
2019-04-02 13:19:22 | Fresenius Medical Care to pay $231M to resolve bribery charges